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What diagnosis can be suspected and which tests can
be used to confirm this?
The combination of congenital eyelid ptosis and severe ortho-
static hypotension with preserved heart rate acceleration sug-
gests sympathetic failure with intact parasympathetic func-
tion. Sweating, sympathetically mediated by acetylcholine,
was intact, which implies that there was isolated absence of
noradrenergic sympathetic function. Indeed, noradrenaline
and adrenaline in plasma at rest and after standing were below
detection limits (<0.01 nmol/L, normal values 0.4–3 nmol/L
and 0.012–0.2 nmol/L respectively), whereas the dopamine
level was greatly increased (1.1 nmol/L, normal values
0.02–0.19 nmol/L). These very low plasma levels of
noradrenaline and adrenaline with an increased level of dopa-
mine in this young adult patient are typical of dopamine beta
hydroxylase (DBH) deficiency. DBH deficiency in this patient
was genetically confirmed, with homozygous known patho-
genic variants (IVS1 + 2 T > C) of the DBH gene (chromo-
some locus 9q34.2) [1]. As shown in Fig. 1, DBH is the
enzyme that converts dopamine to noradrenaline.
Noradrenaline can then be further converted to adrenaline.
DBH deficiency is an extremely rare metabolic disorder of
catecholamine synthesis, described in less than 20 patients
worldwide. It leads to a lack of sympathetic noradrenergic
function with normal parasympathetic and cholinergic-
mediated sympathetic function, as is extensively reviewed
by Robertson and Garland [2]. In DBH deficiency, the auto-
nomic nervous system is structurally intact, but functionally
impaired by the lack of noradrenaline, which leads to pro-
found orthostatic hypotension and mild eyelid ptosis, but has
no effect on sweating. In most patients, baroreflex afferents to
the heart are at least partially intact, as demonstrated by the
increase in heart rate on standing [3].
In DBH deficiency, it is described that orthostatic hypoten-
sionmostly becomes manifest during adolescence. The reason
for this relatively late presentation in the context of severe
catecholamine deficiency from birth onward is unknown. It
may be partly due to tardy recognition, as was probably the
case in our patient. In general, orthostatic intolerance is often
considered and evaluated in puberty and adulthood, but not in
childhood. We are not aware of studies on normal values for
blood pressure after orthostatic provocation in young children.
Moreover, orthostatic complaints may become more apparent
during puberty, because children may be protected from it
owing to reduced gravitational force on their limited body
height, or because of increased angiotensin II levels in child-
hood. Angiotensin II is part of the neurohumoral response on
standing [4].
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What could be an explanation for the mitochondrial
abnormalities in the proximal tubule,
and the decreased glomerular filtration rate
in this patient?
Electron microscopy of the kidney biopsy (Fig. 2) showed
notable mitochondrial abnormalities, with extensive mito-
chondrial fusion and mitochondria with irregular shape
and/or loss of cristae. This indicates mitochondrial dys-
function, especially in the activity of fission and fusion,
which is critical for preserving normal cellular physiology
[5], and can be an indicator of changed environmental
conditions. No histological abnormalities were seen at
the distal tubules, and mitochondrial function in muscle
tissue was normal, suggesting a local damaging factor in
the proximal tubule in our patient. A possible damaging
factor here is the high L-DOPA concentration in proximal
tubules, because of increased filtered load and enhanced
transport of L-DOPA in this compartment [6]. In DBH
deficiency, plasma L-DOPA concentration is doubled [1, 3].
L-DOPA is metabolized to dopamine inside the proximal tu-
bular cells and dopamine is transported out of the cell to acti-
vate dopamine receptors. In urine, the concentration of dopa-
mine is about 1,000 times the serum concentration and a small
increase in L-DOPA concentration can lead to greatly in-
creased dopamine levels [7]. Goldstein et al. reviewed the
inherent cytotoxicity of catecholamines including dopamine
in cells in which they are produced [8, 9]. Monoamine oxidase
(MAO), one of the enzymes that metabolize dopamine to its
inactive metabolite homovanillic acid, yields hydrogen perox-
ide, resulting in the production of reactive oxygen species
(ROS). Increased production of mitochondria-derived
ROS was shown in opossum proximal tubular cells treat-
ed with dopamine in a concentration-dependent manner
[10]. Mitochondrial DNA is particularly susceptible to
modification by ROS [11]. Furthermore, mitochondrial
toxicity can be due to increased levels of quinones, which
are intermediates in L-DOPA metabolism [12].
Fig. 2 Electron microscopy of kidney biopsy showing notable abnormal
mitochondria. Star basal membrane, BB brush border proximal tubule.
Inset: swollen mitochondria exhibit electron-lucent areas (arrowhead),
fused mitochondria present as amorphous matrix densities (arrow)
Fig. 1 Simplified scheme of catecholamine biosynthesis. The diagram
shows how catecholamines (dopamine, noradrenaline, and adrenaline)
are formed from tyrosine and L-DOPA, and how they are metabolized
to homovanillic acid (HVA) and vanillylmandelic acid (VMA). Enzymes,
represented in ovals, are abbreviated: TH tyrosine hydroxylase,
AADC aromatic l-amino acid decarboxylase, DBH dopamine beta
hydroxylase, PNMT phenylethanolamine N-methyltransferase. The
metabolic block in DBH deficiency can be bypassed by supplying the
patient with L-DOPS, represented in a capsule. Dashed arrows do not
show intermediate steps/enzymes
Fig. 3 Repeated measurements of estimated glomerular filtration rate
(eGFR; ml/min/1.73 m2) in our patient with DBH deficiency, showing
decreased eGFR (<60 ml/min/1.73 m2. After she started on L-DOPS, her
eGFR increased to between 68 and 78 ml/min/1.73 m2
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Besides mitochondrial dysfunction, the function of the
tubuloglomerular system itself may be an explanation for the
decreased eGFR in our patient. Dopamine leads to decreased
reabsorption of sodium in the proximal tubule and loop of
Henle, and this could initiate a vasoconstrictor response in the
afferent arteriole via a Na+-K+-2Cl− cotransporter, and a vaso-
dilator response, probably via the Na+ transporter in the
connecting tubule. Both transporters, however, are inhibited by
dopamine. Dopamine can also directly stimulate renin expres-
sion and release [13]. It is difficult to predict the effect of in-
creased dopamine on glomerulotubular balance. Other factors,
caused by defective reabsorption by damaged proximal tubular
cells such as succinic acid, can stimulate the system [14].
However, dopaminergic stimulation of the tubuloglomerular
feedback system leading to reduced filtration pressure remains
an attractive possibility.
Decreased kidney function was found in 4 out of 9 patients
with DBH deficiency [2]. Garland et al. proposed that a de-
crease in renal perfusion may lead to renal damage in patients
with autonomic failure [15]. However, if hypoperfusion leading
to hypoxia would be the main explanation of kidney failure in
this patient group, tubulointerstitial fibrosis would be expected
[16]. Fibrosis was only discreetly seen in our patient (Fig. 2).
Is treatment possible?
Dopamine beta hydroxylase deficiency can be treated success-
fully by using L-threo-3,4-dihydroxyphenylserine (L-DOPS,
droxidopa), which is converted directly to noradrenaline by
aromatic L-amino acid decarboxylase (AADC), thereby
bypassing the metabolic block (Fig. 1) [17, 18]. With L-
DOPS treatment, patients no longer experience the symptoms
associated with orthostatic hypotension [19], have an in-
creased exercise tolerance, and markedly improved quality
of life [20]. Our patient also achieved an impressive functional
improvement after starting on L-DOPS. Furthermore, her
eGFR showed a significant improvement, as is shown in
Fig. 3. The negative effects of high dopamine levels on the
kidney, therefore, whatever their exact mechanism, seemed to
be reversible in this patient. The serum magnesium concentra-
tion before (0.64–0.77 mmol/L) and during (0.64–0.78 mmol/
L) L-DOPS treatment remained in the low normal or subnor-
mal range, with increased fractional urinary magnesium ex-
cretion (7.25–9.75 %, normally <4 %) during both states. The
renal function study in this patient is a strong impetus for
further detailed studies in more patients with DBH deficiency.
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